Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Martin

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
The Medical Journal of Australia|June 4, 2016
Medicinal cannabis in Australia: the missing linksJennifer H Martin, Yvonne A Bonomo
Clinical Pharmacokinetics|February 18, 2016
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia SyndromeStephanie E Reuter, Jennifer H Martin
The Medical Journal of Australia|May 7, 2020
Drug repurposing in the era of COVID-19: a call for leadership and government investmentJennifer H Martin, Nikola A Bowden
British Journal of Clinical Pharmacology|July 11, 2019
Parasitic pharmacology: A plausible mechanism of action for cannabidiolGeert Jan Groeneveld, Jennifer H Martin
British Journal of Clinical Pharmacology|August 10, 2020
Taking the brake off the immune system: Hypotheses, trials, tribulations, and the evolving discipline of clinical immunopharmacologyJennifer H Martin, Lionel D Lewis
The Medical Journal of Australia|April 19, 2012
New medicines - urgent need to assess outcomes in special groupsJennifer H Martin, Michael D Coory
Pharmacology Research & Perspectives|December 3, 2019
DRUG REPURPOSING-Overcoming the translational hurdles to clinical useJennifer H Martin, Nikola A Bowden
Expert Opinion on Pharmacotherapy|January 24, 2017
Lipid and other management to improve arterial disease and survival in end stage renal diseaseSimon B Dimmitt, Jennifer H Martin
Pharmacology Research & Perspectives|February 2, 2022
Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacologyJennifer H Martin, Richard J Head
The Medical Journal of Australia|August 24, 2019
Intensive lipid-lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysisSimon B Dimmitt, Jennifer H Martin
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
The Medical Journal of Australia|June 4, 2016
Medicinal cannabis in Australia: the missing linksJennifer H Martin, Yvonne A Bonomo
Clinical Pharmacokinetics|February 18, 2016
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia SyndromeStephanie E Reuter, Jennifer H Martin
The Medical Journal of Australia|May 7, 2020
Drug repurposing in the era of COVID-19: a call for leadership and government investmentJennifer H Martin, Nikola A Bowden
British Journal of Clinical Pharmacology|July 11, 2019
Parasitic pharmacology: A plausible mechanism of action for cannabidiolGeert Jan Groeneveld, Jennifer H Martin
British Journal of Clinical Pharmacology|August 10, 2020
Taking the brake off the immune system: Hypotheses, trials, tribulations, and the evolving discipline of clinical immunopharmacologyJennifer H Martin, Lionel D Lewis
The Medical Journal of Australia|April 19, 2012
New medicines - urgent need to assess outcomes in special groupsJennifer H Martin, Michael D Coory
Pharmacology Research & Perspectives|December 3, 2019
DRUG REPURPOSING-Overcoming the translational hurdles to clinical useJennifer H Martin, Nikola A Bowden
Expert Opinion on Pharmacotherapy|January 24, 2017
Lipid and other management to improve arterial disease and survival in end stage renal diseaseSimon B Dimmitt, Jennifer H Martin
Pharmacology Research & Perspectives|February 2, 2022
Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacologyJennifer H Martin, Richard J Head
The Medical Journal of Australia|August 24, 2019
Intensive lipid-lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysisSimon B Dimmitt, Jennifer H Martin
Pageof 19